The Claim
Daily supplementation with 3 grams of omega-3 fatty acids for two months does not significantly reduce C-reactive protein or interleukin-6 levels in adults with end-stage kidney disease undergoing hemodialysis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking omega-3 supplements every day for two months doesn't seem to lower markers of inflammation in people with advanced kidney disease who are on dialysis.
See the scientific wording
Two months of daily omega-3 fatty acid supplementation at 3 grams per day does not significantly reduce C-reactive protein or interleukin-6 levels in adults with end-stage kidney disease undergoing hemodialysis, suggesting that short-term supplementation may not be sufficient to modulate systemic inflammation in this population.
In people with severe kidney failure, the body can't process omega-3 fatty acids properly, so even when they take a lot, the molecules don't get turned into substances that can calm down inflammation. At the same time, the buildup of waste products in the blood keeps immune cells activated, so inflammation stays high no matter how much omega-3 is given.
What the research says
1 studyThis study gave people with advanced kidney disease on dialysis omega-3 pills every day for two months and found their inflammation levels didn’t go down — so the pills didn’t help reduce inflammation in this group.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.